Semaglutide
August 22, 2023
Semaglutide is a medication classified as a GLP-1 (glucagon-like peptide-1) receptor agonist initially approved for patients with type 2 diabetes in adjunct with diet and exercise. The drug essentially mimics the endogenous peptide
